Publications
22
Citations
1,142
Est. group size
—
Recurring co-author estimate
Active years
14
Publishing since 2013
Typically publishes in teams of ~13 · 7% small-team papers (≤3 authors) · across 14 venues
- Global, Population and Genetic Evidence on the Relationships Between Immune‐Mediated Inflammatory Disease and Cancer Risk
Cancer Innovation · 2026
- Plasma metabolomics enhances risk prediction for lung cancer: a population-based validation study
Cancer Letters · 2026
- Uptake and associated factors of breast cancer screening using mammography and ultrasound in China: A multicenter population-based study
Chinese Medical Journal · 2026
- Global Trajectories of Colorectal Cancer Burden From 1990 to 2021 and Projection to 2040
Cancer Innovation · 2025
- The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study
PLoS Medicine · 2025
- An early prediction model for gestational diabetes mellitus created using machine learning algorithms
International Journal of Gynecology & Obstetrics · 2025
- Evaluation of the Long-Term Benefits and Cost-Effectiveness of Colorectal Cancer Screening for Populations with Excess Weight — China, 2023
China CDC Weekly · 2025
- The cascade integration model based on machine learning to predict gestational diabetes
Engineering Research Express · 2024
- LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer
Cancers · 2023
- Comprehensive evaluation of cell death-related genes as novel diagnostic biomarkers for breast cancer
Heliyon · 2023
- Constructing Ontology of Brain Areas and Autism to Support Domain Knowledge Exploration and Discovery
International Journal of Computational Intelligence Systems · 2021
- Evaluation of Nano-Particulate-Matter-Induced Lung Injury in Mice Using Quantitative Micro-Computed Tomography
Journal of Nanoscience and Nanotechnology · 2021
- Impacts of Autofluorescence on Fluorescence Based Techniques to Study Microglia
Research Square · 2021
- Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro
Antiviral Research · 2020
- Immunoglobulin fragment F(ab’) <sub>2</sub> against RBD potently neutralizes SARS-CoV-2 in vitro
bioRxiv (Cold Spring Harbor Laboratory) · 2020
- Chinese Medical Journal×2
- Cancer Innovation×2
- Nature Nanotechnology×1
- Nature Biomedical Engineering×1
- Antiviral Research×1
- Electra D. Paskett
Medicine · The Ohio State University
- Electra D. Paskett
Medicine · The Ohio State University
- Cecilia R. DeGraffinreid
Medicine · The Ohio State University
- Chasity Washington
Medicine · The Ohio State University
- Gregory Young
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile